Related Experiment Video

Updated: Sep 21, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Improved survival of idiopathic dilated cardiomyopathy in the 1990s

A Azuma1, A Matsuo, T Nakamura

  • 1Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.

Japanese Circulation Journal
|August 16, 2000
PubMed

Insights

Recent advancements in dilated cardiomyopathy (DCM) treatment significantly improved patient survival after 1990. Increased use of beta-blockers and ACE inhibitors, alongside reduced digitalis use, contributed to better outcomes in DCM patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure with historically poor long-term survival.
  • Treatment strategies for DCM have evolved over recent decades, necessitating an analysis of their impact on patient outcomes.
  • Understanding changes in survival rates is crucial for evaluating the effectiveness of contemporary medical interventions.

Purpose of the Study:

  • To investigate the recent changes in long-term survival rates among patients diagnosed with dilated cardiomyopathy (DCM).
  • To compare survival outcomes between patients diagnosed before 1989 and those diagnosed after 1990.
  • To identify potential therapeutic factors contributing to any observed changes in survival.

Main Methods:

  • A retrospective study of 111 consecutive DCM patients with ejection fraction <50% and left ventricular end-diastolic diameter >58 mm.
  • Patients were divided into two groups based on diagnosis period: Group A (before 1989) and Group B (after 1990).
  • Comparison of baseline characteristics, medication usage (beta-blockers, ACE inhibitors, digitalis), and survival rates (5-year survival, event-free survival) between the groups.

Main Results:

  • Five-year survival rate was significantly higher in Group B (90.0%) compared to Group A (62.3%).
  • Event-free survival also demonstrated improvement in Group B.
  • Group B showed increased use of beta-blockers and angiotensin-converting enzyme inhibitors, and decreased use of digitalis and inotropic agents compared to Group A. Left ventricular ejection fraction improved with beta-blocker therapy.

Conclusions:

  • A significant improvement in the long-term survival of dilated cardiomyopathy patients has been observed since 1990.
  • The enhanced survival is strongly associated with changes in medical treatment, particularly the increased utilization of beta-blockers.
  • These findings underscore the importance of guideline-directed medical therapy, including beta-blockers, in managing DCM.

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...